Atividade antiviral in vitro de compostos naturais como potenciais alternativas contra o SARS-CoV-2
| Ano de defesa: | 2023 |
|---|---|
| Autor(a) principal: | |
| Orientador(a): | |
| Banca de defesa: | |
| Tipo de documento: | Dissertação |
| Tipo de acesso: | Acesso aberto |
| Idioma: | por |
| Instituição de defesa: |
Não Informado pela instituição
|
| Programa de Pós-Graduação: |
Não Informado pela instituição
|
| Departamento: |
Não Informado pela instituição
|
| País: |
Não Informado pela instituição
|
| Área do conhecimento CNPq: | |
| Link de acesso: | http://repositorio.ufc.br/handle/riufc/78268 |
Resumo: | In March 2020, the World Health Organization (WHO) declared the Covid-19 pandemic, caused by the SARS-CoV-2 virus, becoming an unprecedented global problem in human health, social stability and, subsequently, a socioeconomic problem. Natural products and their structural molecules have historically contributed to pharmacotherapy, acting as a source of molecules with different biological activities, emphasizing their action against cancer, infectious diseases, and potent antiviral inhibitors. In this context, Brazilian biodiversity, given its richness, presents itself as a promising source in bioprospecting and in the development of molecules with potential biological applications. This work, the flavonoids: kaempferol and alpha-bisabolol, as well as vitamin E (alpha-tocopherol), were evaluated for their potential as an antiviral agent. For this purpose, in vitro assays were conducted to evaluate the cytotoxic potential of the molecules by MTT assays and, later, PRNT viral neutralization assays in Vero cell line against the Delta lineage of SAR-CoV-2. From the cytotoxicity assays, the concentrations were determined for each molecule with a cytotoxic potential lower than 30%, being 25, 6.25 and 6.25 mg/mL for alpha-tocopherol, kaempferol and alphabisabolol, respectively. These concentrations were used in viral neutralization assays. The PRNT viral neutralization results, when in direct contact with the virus, showed an inhibition percentage of 98.2%, 20.8% and 8.8% for alpha-tocopherol, kaempferol and alpha-bisabolol, respectively. To evaluate the possible mechanism of action of the molecule, in silico molecular docking assays were performed against three targets of viral RNA polymerase proteins RdRp, Mpro and Spike. In molecular anchoring, alphatocopherol obtained the best energy performance, followed by kaempferol and alphabisabolol, with the difference that alpha-tocopherol obtained a triple mode of action Mpro, RdRp and Spike. The present work presented the in vitro anti-SARS-CoV-2 antiviral activity of alpha-tocopherol, as well as its interaction with sites of importance in viral replication, which may indicate the potential of this molecule in the treatment of Covid-19, thus emphasizing the importance of studies aimed at establishing new alternatives for the discovery of antiviral agents. |
| id |
UFC-7_4438dca92b94d47dbe1af23368739b0a |
|---|---|
| oai_identifier_str |
oai:repositorio.ufc.br:riufc/78268 |
| network_acronym_str |
UFC-7 |
| network_name_str |
Repositório Institucional da Universidade Federal do Ceará (UFC) |
| repository_id_str |
|
| spelling |
Sousa, Vânia Carla deFernandes, Carla Freire CeledonioFernandes, Cléberson de Freitas2024-09-24T12:20:37Z2024-09-24T12:20:37Z2023SOUSA, Vânia Carla de. Atividade antiviral in vitro de compostos naturais como potenciais alternativas contra o SARS-CoV-2. 2023. Dissertação (Mestrado em Biotecnologia de Recursos Naturais)-Universidade Federal do Ceará, Fortaleza, 2024.http://repositorio.ufc.br/handle/riufc/78268In March 2020, the World Health Organization (WHO) declared the Covid-19 pandemic, caused by the SARS-CoV-2 virus, becoming an unprecedented global problem in human health, social stability and, subsequently, a socioeconomic problem. Natural products and their structural molecules have historically contributed to pharmacotherapy, acting as a source of molecules with different biological activities, emphasizing their action against cancer, infectious diseases, and potent antiviral inhibitors. In this context, Brazilian biodiversity, given its richness, presents itself as a promising source in bioprospecting and in the development of molecules with potential biological applications. This work, the flavonoids: kaempferol and alpha-bisabolol, as well as vitamin E (alpha-tocopherol), were evaluated for their potential as an antiviral agent. For this purpose, in vitro assays were conducted to evaluate the cytotoxic potential of the molecules by MTT assays and, later, PRNT viral neutralization assays in Vero cell line against the Delta lineage of SAR-CoV-2. From the cytotoxicity assays, the concentrations were determined for each molecule with a cytotoxic potential lower than 30%, being 25, 6.25 and 6.25 mg/mL for alpha-tocopherol, kaempferol and alphabisabolol, respectively. These concentrations were used in viral neutralization assays. The PRNT viral neutralization results, when in direct contact with the virus, showed an inhibition percentage of 98.2%, 20.8% and 8.8% for alpha-tocopherol, kaempferol and alpha-bisabolol, respectively. To evaluate the possible mechanism of action of the molecule, in silico molecular docking assays were performed against three targets of viral RNA polymerase proteins RdRp, Mpro and Spike. In molecular anchoring, alphatocopherol obtained the best energy performance, followed by kaempferol and alphabisabolol, with the difference that alpha-tocopherol obtained a triple mode of action Mpro, RdRp and Spike. The present work presented the in vitro anti-SARS-CoV-2 antiviral activity of alpha-tocopherol, as well as its interaction with sites of importance in viral replication, which may indicate the potential of this molecule in the treatment of Covid-19, thus emphasizing the importance of studies aimed at establishing new alternatives for the discovery of antiviral agents.Em março de 2020, a Organização Mundial de Saúde (OMS) declarou a pandemia da Covid-19, causada pelo vírus SARS-CoV-2, tornando-se um problema global sem precedentes na saúde humana, na estabilidade social e, posteriormente, um problema socioeconômico. Os produtos naturais e suas moléculas estruturais têm contribuído historicamente à farmacoterapia, atuando como fonte de moléculas com diferentes atividades biológicas, enfatizando sua ação contra câncer, doenças infecciosas e potentes inibidores antivirais. Nesse contexto, a biodiversidade brasileira, dada a sua riqueza, se apresenta como fonte promissora na bioprospecção e no desenvolvimento de moléculas com potencial aplicações biológicas. Nesse trabalho foram avaliados os flavonoides: caempferol e alfa-bisabolol, assim como a vitamina E (alfa-tocoferol), quanto ao seu potencial como agente antiviral. Para tanto, foram conduzidos ensaios in vitro para avaliar o potencial citotóxico das moléculas por ensaios de MTT e, posteriormente, ensaios de neutralização viral PRNT em linhagem de células Vero contra a linhagem Delta do SAR-CoV-2. A partir dos ensaios de citotoxicidade foram determinadas as concentrações, para cada molécula, com potencial citotóxico inferior a 30%, sendo 25, 6,25 e 6,25 mg/mL para alfa-tocoferol, caempferol e alfa-bisabolol, respectivamente. Essas concentrações foram utilizadas nos ensaios de neutralização viral. Os resultados de neutralização viral PRNT, quando em contato diretamente com o vírus, mostraram percentual de inibição de 98,2%, 20,8% e 8,8% para o alfatocoferol, caempferol e alfa-bisabolol, respectivamente. Visando avaliar o possível mecanismo de ação da molécula, ensaios in silico de ancoragem molecular foram realizados contra três alvos de proteínas virais de RNA polimerase RdRp, Mpro e Spike. Na ancoragem molecular, o alfa-tocoferol obteve melhor desempenho de energia, seguido pelo caempferol e alfa-bisabolol, com o diferencial que, o alfa-tocoferol obteve triplo modo de ação Mpro, RdRp e Spike. O presente trabalho apresentou a atividade antiviral anti-SARS-CoV-2, in vitro, do alfa-tocoferol, assim como sua interação com sítios de importância na replicação viral, podendo indicar o potencial dessa molécula no tratamento da Covid-19, enfatizando, assim, a importância de estudos que visem estabelecer novas alternativas para descoberta de agentes antivirais.Atividade antiviral in vitro de compostos naturais como potenciais alternativas contra o SARS-CoV-2In vitro antiviral activity of natural compounds as potential alternatives against SARS-CoV-2info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisVitamina ESARS-CoV-2COVID-19Produtos naturaisAntiviraisAgente AntiviralVitamin ESARS-CoV-2COVID-19Natural productsCNPQ::CIENCIAS BIOLOGICASinfo:eu-repo/semantics/openAccessporreponame:Repositório Institucional da Universidade Federal do Ceará (UFC)instname:Universidade Federal do Ceará (UFC)instacron:UFChttps://orcid.org/0009-0003-7172-8410http://lattes.cnpq.br/8687927704314976https://orcid.org/0000-0001-5269-1139http://lattes.cnpq.br/7426209328649448https://orcid.org/0000-0001-8586-2782http://lattes.cnpq.br/39224811120876172024-09-24ORIGINAL2023_dis_vcsousa.pdf2023_dis_vcsousa.pdfapplication/pdf1524236http://repositorio.ufc.br/bitstream/riufc/78268/3/2023_dis_vcsousa.pdf0776239e04539e81b6a26280e81cfc38MD53LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://repositorio.ufc.br/bitstream/riufc/78268/4/license.txt8a4605be74aa9ea9d79846c1fba20a33MD54riufc/782682024-09-24 09:20:39.288oai:repositorio.ufc.br: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Repositório InstitucionalPUBhttp://www.repositorio.ufc.br/ri-oai/requestbu@ufc.br || repositorio@ufc.bropendoar:2024-09-24T12:20:39Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)false |
| dc.title.pt_BR.fl_str_mv |
Atividade antiviral in vitro de compostos naturais como potenciais alternativas contra o SARS-CoV-2 |
| dc.title.en.pt_BR.fl_str_mv |
In vitro antiviral activity of natural compounds as potential alternatives against SARS-CoV-2 |
| title |
Atividade antiviral in vitro de compostos naturais como potenciais alternativas contra o SARS-CoV-2 |
| spellingShingle |
Atividade antiviral in vitro de compostos naturais como potenciais alternativas contra o SARS-CoV-2 Sousa, Vânia Carla de CNPQ::CIENCIAS BIOLOGICAS Vitamina E SARS-CoV-2 COVID-19 Produtos naturais Antivirais Agente Antiviral Vitamin E SARS-CoV-2 COVID-19 Natural products |
| title_short |
Atividade antiviral in vitro de compostos naturais como potenciais alternativas contra o SARS-CoV-2 |
| title_full |
Atividade antiviral in vitro de compostos naturais como potenciais alternativas contra o SARS-CoV-2 |
| title_fullStr |
Atividade antiviral in vitro de compostos naturais como potenciais alternativas contra o SARS-CoV-2 |
| title_full_unstemmed |
Atividade antiviral in vitro de compostos naturais como potenciais alternativas contra o SARS-CoV-2 |
| title_sort |
Atividade antiviral in vitro de compostos naturais como potenciais alternativas contra o SARS-CoV-2 |
| author |
Sousa, Vânia Carla de |
| author_facet |
Sousa, Vânia Carla de |
| author_role |
author |
| dc.contributor.co-advisor.none.fl_str_mv |
Fernandes, Carla Freire Celedonio |
| dc.contributor.author.fl_str_mv |
Sousa, Vânia Carla de |
| dc.contributor.advisor1.fl_str_mv |
Fernandes, Cléberson de Freitas |
| contributor_str_mv |
Fernandes, Cléberson de Freitas |
| dc.subject.cnpq.fl_str_mv |
CNPQ::CIENCIAS BIOLOGICAS |
| topic |
CNPQ::CIENCIAS BIOLOGICAS Vitamina E SARS-CoV-2 COVID-19 Produtos naturais Antivirais Agente Antiviral Vitamin E SARS-CoV-2 COVID-19 Natural products |
| dc.subject.ptbr.pt_BR.fl_str_mv |
Vitamina E SARS-CoV-2 COVID-19 Produtos naturais Antivirais Agente Antiviral |
| dc.subject.en.pt_BR.fl_str_mv |
Vitamin E SARS-CoV-2 COVID-19 Natural products |
| description |
In March 2020, the World Health Organization (WHO) declared the Covid-19 pandemic, caused by the SARS-CoV-2 virus, becoming an unprecedented global problem in human health, social stability and, subsequently, a socioeconomic problem. Natural products and their structural molecules have historically contributed to pharmacotherapy, acting as a source of molecules with different biological activities, emphasizing their action against cancer, infectious diseases, and potent antiviral inhibitors. In this context, Brazilian biodiversity, given its richness, presents itself as a promising source in bioprospecting and in the development of molecules with potential biological applications. This work, the flavonoids: kaempferol and alpha-bisabolol, as well as vitamin E (alpha-tocopherol), were evaluated for their potential as an antiviral agent. For this purpose, in vitro assays were conducted to evaluate the cytotoxic potential of the molecules by MTT assays and, later, PRNT viral neutralization assays in Vero cell line against the Delta lineage of SAR-CoV-2. From the cytotoxicity assays, the concentrations were determined for each molecule with a cytotoxic potential lower than 30%, being 25, 6.25 and 6.25 mg/mL for alpha-tocopherol, kaempferol and alphabisabolol, respectively. These concentrations were used in viral neutralization assays. The PRNT viral neutralization results, when in direct contact with the virus, showed an inhibition percentage of 98.2%, 20.8% and 8.8% for alpha-tocopherol, kaempferol and alpha-bisabolol, respectively. To evaluate the possible mechanism of action of the molecule, in silico molecular docking assays were performed against three targets of viral RNA polymerase proteins RdRp, Mpro and Spike. In molecular anchoring, alphatocopherol obtained the best energy performance, followed by kaempferol and alphabisabolol, with the difference that alpha-tocopherol obtained a triple mode of action Mpro, RdRp and Spike. The present work presented the in vitro anti-SARS-CoV-2 antiviral activity of alpha-tocopherol, as well as its interaction with sites of importance in viral replication, which may indicate the potential of this molecule in the treatment of Covid-19, thus emphasizing the importance of studies aimed at establishing new alternatives for the discovery of antiviral agents. |
| publishDate |
2023 |
| dc.date.issued.fl_str_mv |
2023 |
| dc.date.accessioned.fl_str_mv |
2024-09-24T12:20:37Z |
| dc.date.available.fl_str_mv |
2024-09-24T12:20:37Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
| format |
masterThesis |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
SOUSA, Vânia Carla de. Atividade antiviral in vitro de compostos naturais como potenciais alternativas contra o SARS-CoV-2. 2023. Dissertação (Mestrado em Biotecnologia de Recursos Naturais)-Universidade Federal do Ceará, Fortaleza, 2024. |
| dc.identifier.uri.fl_str_mv |
http://repositorio.ufc.br/handle/riufc/78268 |
| identifier_str_mv |
SOUSA, Vânia Carla de. Atividade antiviral in vitro de compostos naturais como potenciais alternativas contra o SARS-CoV-2. 2023. Dissertação (Mestrado em Biotecnologia de Recursos Naturais)-Universidade Federal do Ceará, Fortaleza, 2024. |
| url |
http://repositorio.ufc.br/handle/riufc/78268 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da Universidade Federal do Ceará (UFC) instname:Universidade Federal do Ceará (UFC) instacron:UFC |
| instname_str |
Universidade Federal do Ceará (UFC) |
| instacron_str |
UFC |
| institution |
UFC |
| reponame_str |
Repositório Institucional da Universidade Federal do Ceará (UFC) |
| collection |
Repositório Institucional da Universidade Federal do Ceará (UFC) |
| bitstream.url.fl_str_mv |
http://repositorio.ufc.br/bitstream/riufc/78268/3/2023_dis_vcsousa.pdf http://repositorio.ufc.br/bitstream/riufc/78268/4/license.txt |
| bitstream.checksum.fl_str_mv |
0776239e04539e81b6a26280e81cfc38 8a4605be74aa9ea9d79846c1fba20a33 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC) |
| repository.mail.fl_str_mv |
bu@ufc.br || repositorio@ufc.br |
| _version_ |
1847793233827987456 |